Credit Agricole’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Credit Agricole’s Portfolio SIOX Stock Details SIOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-375	Closed	-$1K	–	771
2021 Q1	$1K	Hold	375	–	–	﹤0.01%	624
2020 Q4	$1K	Hold	375	–	–	﹤0.01%	548
2020 Q3	$2K	Hold	375	–	–	﹤0.01%	490
2020 Q2	$1K	Hold	375	–	–	﹤0.01%	455
2020 Q1	$1K	Hold	375	–	–	﹤0.01%	455
2019 Q4	$2K	Hold	375	–	–	﹤0.01%	419
2019 Q3	$2K	Hold	375	–	–	﹤0.01%	489
2019 Q2	$2K	Hold	375	–	–	﹤0.01%	473
2019 Q1	$4K	Hold	375	–	–	﹤0.01%	454
2018 Q4	$3K	Hold	375	–	–	﹤0.01%	447
2018 Q3	$7K	Buy	+375	New	+$6.82K	﹤0.01%	416
2017 Q2	–	Sell	-114,473	Closed	-$110M	–	1627
2017 Q1	$110M	Buy	+114,473	New	+$12M	0.34%	61

Other funds holding SIOX

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

TVWM

Tower View Wealth Management Shorewood, Wisconsin $195M AUM 29.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Credit Agricole's SIOX Position: Q2 2021 in Review

Credit Agricole sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q2 2021, closing a stake of 375 shares — an estimated $1K sold.

Credit Agricole first reported a position in SIOX in Q1 2017 and held it in 12 quarters. The position peaked at $110M in Q1 2017. 54 funds tracked by Wall St. Rank hold SIOX as of Q2 2021.

Credit Agricole reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Credit Agricole sold 375 Sio Gene Therapies Inc. Common Stock shares in Q2 2021, an estimated $1K.
Credit Agricole first reported a position in Sio Gene Therapies Inc. Common Stock in Q1 2017 and held it in 12 quarters.
Credit Agricole's Sio Gene Therapies Inc. Common Stock position peaked at $110M in Q1 2017.
54 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q2 2021.

Based on Credit Agricole's 13F filing for Q2 2021, filed 10 Aug 2021.